LUTHERVILLE, Md., April 17, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest quarterly results achieved by the real-time, stop-sale system in Washington State. The National Precursor Log Exchange (NPLEx) released quarterly data for 2012 which shows electronic technology in the Evergreen State blocked the sale of more than 4,300 boxes of medicines containing pseudoephedrine (PSE) preventing more than 9,700 grams from potentially being diverted by meth criminals.
"It's been less than six months since the state of Washington fully implemented NPLEx. In that short amount of time, the real-time, stop-sale technology has already demonstrated impressive results," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "NPLEx is a reasonable and effective solution to Washington's meth problem that targets criminals and protects responsible citizens' access to popular and reliable medicines containing pseudoephedrine. Much like a credit card transaction, retailers are able to block unlawful purchases right at the sales counter. This data is generated in real time and provided to law enforcement officials who use it to track down and arrest meth offenders. All citizens should be pleased by the early success of NPLEx in Washington State."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators